Novo Nordisk’s Wegovy and copyright, equally run by semaglutide, have revolutionized obesity therapy by way of unprecedented weight loss results. California biotech behemoth Amgen ditched designs for an experimental weight loss pill in Might but is still hoping for just a slice of the m